CE/CME

Irritable Bowel Syndrome: Evidence-based Treatment

Author and Disclosure Information

Although accreditation for this CE/CME activity has expired, and the posttest is no longer available, you can still read the full article.

Expires January 31, 2015

Irritable bowel syndrome (IBS), a functional gastrointestinal disorder usually manifesting with abdominal pain and altered bowel movements, is often seen in primary care. With the recent advances in evidence-based knowledge, you can now more readily make a diagnosis and offer your patients with IBS a variety of treatment options tailored to their needs.


 

References


CE/CME No: CR-1401

PROGRAM OVERVIEW
Earn credit by reading this article and successfully completing the posttest. Successful completion is defined as a cumulative score of at least 70% correct.

EDUCATIONAL OBJECTIVES
• Describe the criteria for diagnosis of irritable bowel syndrome (IBS).
• List three dietary interventions that may reduce symptoms of IBS.
• Discuss the role of probiotics in the treatment of IBS.
• List three classes of prescription medication that may reduce symptoms of IBS.

FACULTY
Suzanne Martin is an Assistant Professor at the University of Utah College of Nursing and works as a family nurse practitioner at the University of Utah Student Health Center in Salt Lake City.
The author has no financial disclosures to report.

ACCREDITATION STATEMENT

This program has been reviewed and is approved for a maximum of 1.0 hour of American Academy of Physician Assistants (AAPA) Category I CME credit by the Physician Assistant Review Panel. [NPs: Both ANCC and the AANP Certification Program recognize AAPA as an approved provider of Category 1 credit.] Approval is valid for one year from the issue date of January 2014.

Article begins on next page >>

Pages

Next Article: